Infection control stocks skyrocket as COVID-19 cases rebound - koreatimes
| 205470 Stock | KRW 1,864 21.00 1.11% |
About 61% of Humasis' investor base is looking to short. The analysis of current outlook of investing in Humasis Co suggests that many traders are alarmed regarding Humasis' prospects. The current market sentiment, together with Humasis' historical and current headlines, can help investors time the market. In addition, many technical investors use Humasis stock news signals to limit their universe of possible portfolio assets.
Humasis |
Infection control stocks skyrocket as COVID-19 cases rebound koreatimes
Read at news.google.com
 |
Humasis Fundamental Analysis
We analyze Humasis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humasis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humasis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Humasis is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Humasis Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Humasis stock to make a market-neutral strategy. Peer analysis of Humasis could also be used in its relative valuation, which is a method of valuing Humasis by comparing valuation metrics with similar companies.
Peers
Humasis Related Equities
| 036200 | UNISEM | 1.65 | ||||
| 084650 | LabGenomics | 1.12 | ||||
| 011390 | Busan Industrial | 0.89 | ||||
| 096530 | Seegene | 0.22 | ||||
| 133820 | Finebesteel | 0.71 |
Complementary Tools for Humasis Stock analysis
When running Humasis' price analysis, check to measure Humasis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humasis is operating at the current time. Most of Humasis' value examination focuses on studying past and present price action to predict the probability of Humasis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humasis' price. Additionally, you may evaluate how the addition of Humasis to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |